Artículo de revista
II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina
Fecha
2015Registro en:
Revista médica de Chile. Volumen: 143 Número: 5 Páginas: 627-636
DOI: 10.4067/S0034-98872015000500012
Autor
Pollak, Felipe
Araya Quintanilla, Verónica
Lanas Montecinos, Alejandra
Sapunar, Jorge
Carrasco Naranjo, Fernando
Codner Dujovne, Ethel
Durruty Alfonso, Pilar
Liberman Guendelman, Claudio
López Stewart, Gloria
Poniachik Teller, Jaime
Sir Petermann, Teresa
Soto, Néstor
Institución
Resumen
Insulin resistance is a prevalent condition commonly associated with unhealthy lifestyles. It affects several metabolic pathways, increasing risk of abnormalities at different organ levels. Thus, diverse medical specialties should be involved in its diagnosis and treatment. With the purpose of unifying criteria about this condition, a scientific-based consensus was elaborated. A questionnaire including the most important topics such as cardio-metabolic risk, non-alcoholic fatty liver disease and polycystic ovary syndrome, was designed and sent to national experts. When no agreement among them was achieved, the Delphi methodology was applied. The main conclusions reached are that clinical findings are critical for the diagnosis of insulin resistance, not being necessary blood testing. Acquisition of a healthy lifestyle is the most important therapeutic tool. Insulin-sensitizing drugs should be prescribed to individuals at high risk of disease according to clinically validated outcomes. There are specific recommendations for pregnant women, children, adolescents and older people.